UK small-cap RNS · 15 Apr 2026
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus the ones that are part of a situation. Not investment advice.
Sort: Newest · Largest companies
-
17:00
IP Group IPO £616mAnnual Report ResultsIP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, announces that it has published its Annual Report and Accounts for the …+5.6% on the day
-
09:17
Central Asia Metals CAML £231mAnnual Report and Accounts 2025 and Notice of AGM ResultsAnnual Report and Accounts 2025, Sustainability Report and Notice of 2026 Annual General Meeting−0.9% on the day
-
07:00
Kosmos Energy KOS £1,224mFirst Quarter Results Date ResultsDALLAS, Texas April 15, 2026 - Kosmos Energy (NYSE/LSE: KOS) announced today the following schedule for its first quarter 2026 results:−0.8% on the day
-
07:00
Bow Street Group PLC BOW £8.4mFinal Results Results("Bow Street Group", the "Group" or the "Company")in linefirst in 6 months +5.1% on the day
-
07:00
Saga SAGA £1,165mFinal Results ResultsUnaudited preliminary results for the year ended 31 January 2026ahead of expectationsfirst in 6 months +6.0% on the day
-
07:00
Hvivo HVO £38mFinal Results ResultsRevenue of £46.8m matches the £46.7m flagged in January and EBITDA stays positive. But revenue is down on cancelled HCTs, margin is 3.0% versus 26.2%, cash is £14.3m and there is no dividend; 2026 guidance is only repeated.£46.8m · 123% of mcapoutlook mixedfirst in 2 year −2.9% on the dayMoved: Commence annual dividend payment in 2024: pending → missed – The Board will not pay even a nominal dividend for 2025, citing reinvestment and liquidity, so the promised annual dividend has not started. · Appoint a new permanent Chair: pending → delivered – Shaun Chilton is Chair and has served six months, so a permanent Chair is in place. · Sign and run ILiAD Phase 3 whooping cough challenge trial, expected to start H2 : pending → delayed – The ILiAD challenge trial, expected to start in H2 2025, is still being negotiated and no agreement is signed.
-
07:00
FY 2025 Results ResultsAudited FY2025 confirms the profit doubling flagged in December and January (about USD 57m prelim vs 56.5m reported), with ROE at 44%, cost-income ratio down and a doubled dividend.outlook positivefirst in 6 months +7.0% on the dayMoved: India deconsolidation / ASA India sale: No sale update; India still reported in the group → Deconsolidation targeted for end-2026 · Digital transformation (T24 migration): Ghana done; Tanzania migration planned Q1 2026 → Ghana and Tanzania migrated; Pakistan done
-
07:00
Petards Group PEG £5.2mFinal Results ResultsFull-year results confirm the recovery after a weak 2024: revenue up 24%, adjusted EBITDA up to £1.0m, a smaller loss and lower net debt. Q1 2026 earnings are in line with the Board's expectations.£9.2m · 177% of mcapin lineoutlook positivefirst in 6 months −2.1% on the dayMoved: Challenger 3 engineering services contract: Order in the year-end order book → In order book; deliverables due 2026
-
07:00
Proteome Sciences PRM £4.7mFinal Results ResultsFinal results for the year ended 31 December 2025first since Oct 2023 −4.8% on the day
-
07:00
Oracle Power ORCP £5.1mAssay results of up to 71 g/t Au at Northern Zone ResultsImpressive Northern Zone Gold Project Drilling Results Continue+26.0% on the day